SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs immediate resignation as CEO, following reports of alleged relationships and possible national-security concerns, has driven NVDAs sharp selloff and intense debate over succession. Traders are split between buying the dip on confidence in Nvidias business and warning that losing its founder leaves leadership and investigation risks unresolved.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebiuss strong quarterly results were overshadowed by a softer 2026 outlook tied to delayed capacity and sharply higher infrastructure spending, prompting concerns about execution, funding and possible dilution. Traders also blame speculation around Nvidia leadership for adding pressure to AI-related stocks, while bulls argue the selloff overlooks customer demand and prepayments.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas quarterly results beat revenue and EPS expectations, with higher forward revenue guidance and a larger backlog fueling optimism about its defense and autonomous-systems growth. Traders are split as the stock sells off despite the strong report: bulls point to accelerating demand and an earlier profitability target, while skeptics focus on weaker margins, cash burn and dilution; short-squeeze speculation is also prominent.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

A stronger-than-expected Q3 report, positive free cash flow and a record backlog are driving LUNRs sharp rally, with traders also citing its NASA contract pipeline. Bulls see evidence of improving execution and a shift toward space infrastructure, while skeptics point to ongoing losses and uncertainty around converting backlog into sustained profitability.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,110,893. The last known price of Bitcoin is 73,962.09788083 USD and is up 0.65 over the last 24 hours. It is currently trading on 12778 active market(s) with $24,126,519,221.27 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and tests of key support dominate discussion, with traders linking the weakness to broader tech-market pressure and macro concerns; some blame Nvidia-related headlines, while others say the connection is overblown. Bulls are buying the dip and calling the market oversold, while bears warn of further declines and question whether Bitcoin can decouple from risk assets.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the FDAs November 22 decision on Capricors deramiocel for Duchenne muscular dystrophy, with the application focused on preserving upper-limb function. Traders are divided between optimism about approval and a possible short squeeze, and caution that the decision remains uncertain, especially after the earlier advisory committee vote; some also attribute the sharp swings to profit-taking and broader market weakness.

Figure Technology Solutions, Inc. is a blockchain-native capital marketplace, which engages in connecting origination, funding, and secondary market activity. It operates through the following segments: FTI, Markets, and Other. The FTI segment offers Figure Connect which generates ecosystem and technology fees, and originates, sells, and securitizes home equity line of credit (HELOC) loans that it services. The Markets segment utilizes blockchain technology to develop an exchange for digital assets and credit, with new product offerings including providing interest-bearing stable coin deposits. The company was founded by Michael Scott Cagney and June Ou in 2018 and is headquartered in Reno, NV.

Figure Technology Solutions Inc. - Ordinary Shares - Class A

Figure Technology Solutions Inc

Figures Q3 earnings and revenue beat, alongside an expanded share-repurchase authorization, are driving attention. Bulls point to strong growth and the results as support for the long-term story, while bears focus on the stocks struggle to hold its post-earnings gains and cite short pressure.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Reports and speculation around Nvidia CEO Jensen Huangs leadership and personal-conduct controversy have fueled an AI-stock selloff, with traders saying SMCI is falling in sympathy with Nvidia despite its new AMD-powered server shipments. The community is divided between viewing the drop as unjustified spillover and worrying that SMCIs Nvidia ties and its own governance and export-control overhang leave it especially exposed.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Nvidia CEO Jensen Huangs departure and leadership uncertainty have prompted traders to view AMD as a potential beneficiary as customers diversify chip suppliers. The community is divided over whether the move signals durable opportunity for AMD or a short-lived sympathy rally, with skeptics pointing to Nvidias competitive moat and broader AI-demand risks.

Boost Run, Inc. is a provider of scalable cloud infrastructure purpose-built for enterprise AI and high-performance computing workloads. The platform delivers GPU compute, CPU nodes, managed Kubernetes orchestration, and shared storage through an intuitive management console and a robust API layer, enabling organizations to provision and scale resources across thousands of nodes in minutes. The company was founded on September 5, 2025 and is headquartered in Northbrook, IL.

Boost Run Inc. - Ordinary Shares - Class A

Boost Run Inc.

Boost Runs quarterly results are driving attention: revenue surged year over year but fell short of expectations, and the shares sold off sharply. Bulls call the reaction excessive and cite the companys contracted AI-cloud business, while skeptics focus on losses and whether the backlog can translate into sustainable cash flow.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mid Cap Stocks To Follow Now - February 18th

ProShares UltraPro Short QQQ, Ondas, Avadel Pharmaceuticals, Direxion Daily TSLA Bull 2X Shares, and American Airlines Group are the five Mid Cap stocks to watch today, according to MarketBeat's...

Top Medical Stocks To Follow Now - February 18th

Eli Lilly and Company, UnitedHealth Group, Johnson & Johnson, Avadel Pharmaceuticals, AbbVie, Thermo Fisher Scientific, and Medtronic are the seven Medical stocks to watch today, according to...

Best Pharmaceutical Stocks To Watch Today - February 18th

Eli Lilly and Company, Avadel Pharmaceuticals, AbbVie, Novo Nordisk A/S, Pfizer, AstraZeneca, and Vertex Pharmaceuticals are the seven Pharmaceutical stocks to watch today, according to MarketBeat's...

Top Mid Cap Stocks To Consider - February 17th

ProShares UltraPro Short QQQ, Masimo, Direxion Daily TSLA Bull 2X Shares, ZIM Integrated Shipping Services, Avadel Pharmaceuticals, Ondas, and Applied Digital are the seven Mid Cap stocks to watch...

Best Pharmaceutical Stocks To Follow Now - February 17th

Eli Lilly and Company, Avadel Pharmaceuticals, and AbbVie are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of...

Best Pharmaceutical Stocks To Follow Today - February 13th

Eli Lilly and Company, AbbVie, Avadel Pharmaceuticals, Vertex Pharmaceuticals, Rapt Therapeutics, Pfizer, and Gilead Sciences are the seven Pharmaceutical stocks to watch today, according to...

Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Short Interest Down 36.0% in January

Avadel Pharmaceuticals PLC. (NASDAQ:AVDL - Get Free Report) was the target of a large decline in short interest in the month of January. As of January 30th, there was short interest totaling...

Top Mid Cap Stocks To Watch Now - February 12th

ProShares UltraPro Short QQQ, Icon, Fastly, Direxion Daily TSLA Bull 2X Shares, Avadel Pharmaceuticals, American Airlines Group, and Cognex are the seven Mid Cap stocks to watch today, according to...

Pharmaceutical Stocks To Watch Today - February 12th

Eli Lilly and Company, Avadel Pharmaceuticals, AbbVie, Gilead Sciences, and Pfizer are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical...

Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market

Alkermes plc (Nasdaq: ALKS) (Alkermes) and Avadel Pharmaceuticals plc (Nasdaq: AVDL) (Avadel) today announced Alkermes completion of its acquisition of Avadel, a commercial-stage biopharmaceutical...

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.

Avadel Pharmaceuticals plc

Race For Avadel Heats Up: Alkermes Raises Offer To Secure $2.37B Deal After Lundbeck Challenge 

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>The revised transaction has been approved by the board of directors of both Alkermes and Avadel.</li><li>The transaction is expected to close in the first quarter of 2026.</li></ul>Alkermes plc (ALKS) on Wednesday announced an increased offer to acquire Avadel Pharmaceuticals plc (AVDL) after the latter received another acquisition proposal from Lundbeck.Alkermes had decided to acquire all outstanding ordinary shares of Avadel for up to $20 per share in October. However, Avadel <a href="https://stocktwits.com/news-articles/markets/equity/avadel-gets-acquisition-proposal-from-lundbeck-weeks-after-inking-agreement-with-alkermes/cLPQetHRE4T">said</a> last week that it has received an unsolicited proposal from H. Lundbeck A/S to acquire the drugmaker for up to $23 per share, pressuring Alkermes to up their offer.<h2 class="st-heading-2">Terms Of New Deal</h2>Alkermes will<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/alkermes-plc-announces-increased-offer-to-acquire-avadel-pharmaceuticals-plc-302619905.html"> now acquire</a> Avadel for total transaction consideration of up to $22.50 per share, consisting of $21.00 in cash and a non-transferable contingent value right entitling holders to a potential additional cash payment of $1.50 per share. The additional cash payment will be awarded if the U.S. Food and Drug Administration approves Avadel’s Lumryz for the treatment of idiopathic hypersomnia in adults by the end of 2028.The increased offer values Avadel at up to approximately $2.37 billion. The revised transaction has been approved by the board of directors of both Alkermes and Avadel, the companies said. The transaction is expected to close in the first quarter of 2026.The Avadel board of directors now believes that the Lundbeck proposal no longer constitutes a superior proposal. While Lundbeck proposed to buy Avadel for up to $23, higher than Alkermes’ increased offer of $22.5, the terms of the CVR in Alkermes’s increased offer are superior to the terms of the CVR in Lundbeck's proposal, the board noted. The terms of the CVR in the Lundbeck proposal are unlikely to be achieved, they added.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2><a href="https://stocktwits.com/symbol/AVDL">AVDL shares</a> traded 0.5% lower in the pre-market session at the time of writing. On Stocktwits, retail sentiment around AVDL fell from ‘extremely bullish’ to ‘bullish’ territory over the past 24 hours, while message volume remained at ‘high’ levels.AVDL shares have more than doubled this year.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/elbit-systems-grabs-fresh-210-m-israeli-defense-order-on-top-of-a-record-backlog/cLPoeBRREB5">Elbit Systems' Grabs Fresh $210M Israeli Defense Order On Top Of A Record Backlog</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, an Avadel logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Alkermes will now acquire Avadel for total transaction consideration of up to $22.50 per share. 

Alkermes plc

Avadel Pharm Sp ADR

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

AVDL News